nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study
|
Qin, Chunxia |
|
|
48 |
10 |
p. 3228-3237 |
artikel |
2 |
Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review
|
Frood, R. |
|
|
48 |
10 |
p. 3198-3220 |
artikel |
3 |
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
|
Nicolini, Silvia |
|
|
48 |
10 |
p. 3260-3267 |
artikel |
4 |
Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging
|
Minutoli, Fabio |
|
|
48 |
10 |
p. 3041-3042 |
artikel |
5 |
Complicated pubovesical fistula on PET/CT and MRI
|
Aras, Omer |
|
|
48 |
10 |
p. 3335-3336 |
artikel |
6 |
C. Tinoco Mesquita, M. F. Rezende: Nuclear Cardiology Basic and Advanced Concepts in Clinical Practice
|
Squame, Fiorenzo |
|
|
48 |
10 |
p. 3017-3018 |
artikel |
7 |
Dafang Wu: Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook
|
Di Giorgio, Eugenio |
|
|
48 |
10 |
p. 3019 |
artikel |
8 |
Deepening of response to prostate-specific membrane antigen ligand-targeted radioligand therapy beyond end of treatment
|
Derlin, Thorsten |
|
|
48 |
10 |
p. 3343-3344 |
artikel |
9 |
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
|
Ferraro, Daniela A. |
|
|
48 |
10 |
p. 3315-3324 |
artikel |
10 |
Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study
|
Rufini, Vittoria |
|
|
48 |
10 |
p. 3303-3314 |
artikel |
11 |
3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization
|
Grisanti, Fabiana |
|
|
48 |
10 |
p. 3048-3057 |
artikel |
12 |
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)
|
Delgado Bolton, Roberto C. |
|
|
48 |
10 |
p. 3286-3302 |
artikel |
13 |
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
|
van der Doelen, Maarten J. |
|
|
48 |
10 |
p. 3325-3334 |
artikel |
14 |
Equivalent tumor detection for early and late FAPI-46 PET acquisition
|
Ferdinandus, J. |
|
|
48 |
10 |
p. 3221-3227 |
artikel |
15 |
Explaining a XX century horse behaviour
|
Gozzi, Noemi |
|
|
48 |
10 |
p. 3046-3047 |
artikel |
16 |
18F-Boramino acid PET/CT in healthy volunteers and glioma patients
|
Li, Zhu |
|
|
48 |
10 |
p. 3113-3121 |
artikel |
17 |
18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer
|
Zhang, Fengxian |
|
|
48 |
10 |
p. 3250-3259 |
artikel |
18 |
18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
|
Gassert, Felix G. |
|
|
48 |
10 |
p. 3268-3276 |
artikel |
19 |
[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach
|
Tanguy, Julie |
|
|
48 |
10 |
p. 3058-3074 |
artikel |
20 |
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
|
Coughlin, Jennifer M. |
|
|
48 |
10 |
p. 3122-3128 |
artikel |
21 |
First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers
|
Lan, Xiaoli |
|
|
48 |
10 |
p. 3037-3040 |
artikel |
22 |
[68Ga]Ga-PSMA-HBED-CC PET/CT demonstrates to be superior to ceCT in detecting early treatment response in metastatic clear cell renal cell carcinoma
|
Guglielmo, Priscilla |
|
|
48 |
10 |
p. 3337-3339 |
artikel |
23 |
In memoriam: Marion Hendriks-de Jong
|
Krenning, Eric P. |
|
|
48 |
10 |
p. 3026-3028 |
artikel |
24 |
Intravital microscopy of tumor vessel morphology and function using a standard fluorescence microscope
|
Gaustad, Jon-Vidar |
|
|
48 |
10 |
p. 3089-3100 |
artikel |
25 |
Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?
|
Aide, Nicolas |
|
|
48 |
10 |
p. 3043-3045 |
artikel |
26 |
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
|
Weber, Manuel |
|
|
48 |
10 |
p. 3141-3150 |
artikel |
27 |
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
|
Sollini, Martina |
|
|
48 |
10 |
p. 3187-3197 |
artikel |
28 |
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma
|
Merkx, Robin I. J. |
|
|
48 |
10 |
p. 3277-3285 |
artikel |
29 |
Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
|
Gaudieri, Valeria |
|
|
48 |
10 |
p. 3162-3171 |
artikel |
30 |
Pulmonary tumor thrombotic microangiopathy: the role of a lung perfusion SPECT-CT study
|
Antonella, Stefanelli |
|
|
48 |
10 |
p. 3340-3342 |
artikel |
31 |
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
|
Burvenich, Ingrid Julienne Georgette |
|
|
48 |
10 |
p. 3075-3088 |
artikel |
32 |
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
|
Deandreis, Désirée |
|
|
48 |
10 |
p. 3238-3249 |
artikel |
33 |
Reply to Paulo Schiavom Duarte
|
Rogasch, Julian M. M. |
|
|
48 |
10 |
p. 3024-3025 |
artikel |
34 |
Spatially constrained kinetic modeling with dual reference tissues improves 18F-flortaucipir PET in studies of Alzheimer disease
|
Zhou, Yun |
|
|
48 |
10 |
p. 3172-3186 |
artikel |
35 |
Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain
|
Obokata, Naoyuki |
|
|
48 |
10 |
p. 3101-3112 |
artikel |
36 |
Synthesis, preclinical evaluation, and a pilot clinical imaging study of [18F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [68Ga]Ga-DOTA-TATE
|
Xie, Qing |
|
|
48 |
10 |
p. 3129-3140 |
artikel |
37 |
The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community
|
Garibotto, Valentina |
|
|
48 |
10 |
p. 3033-3036 |
artikel |
38 |
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism
|
Monaco, Lavinia |
|
|
48 |
10 |
p. 3020-3021 |
artikel |
39 |
The importance of lung hyperperfusion patterns in COVID-19-related AVDS
|
Jounieaux, Vincent |
|
|
48 |
10 |
p. 3022-3023 |
artikel |
40 |
Weakly supervised deep learning for determining the prognostic value of 18F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type
|
Guo, Rui |
|
|
48 |
10 |
p. 3151-3161 |
artikel |
41 |
Women on board: mind the (gender) gap
|
Gelardi, Fabrizia |
|
|
48 |
10 |
p. 3029-3032 |
artikel |